Evaporative spray effect on reducing injection pain in children

Study of effectiveness of evaporative spray on intravenous catheterization pain in Imam Reza Hospital in Sirjan 2014

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201406057844N4

Enrollment

Registered

2014-11-19

Start date

2014-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children hospitalized in Imam Reza Hospital in Sirjan.

Interventions

Intervention 1: Intervention group: Researcher prior to venipuncture to children and their parents participated in intervention group, branoll and supplies for venipuncture showed and describeto the a

Treatment - Drugs

Intervention group: Researcher prior to venipuncture to children and their parents participated in intervention group, branoll and supplies for venipuncture showed and describeto the about how to open

Control group: In the control group used of placebo spray that Similar to the form used in the intervention group but with normal Saylyn . How to use a placebo spray Practice of opening vein and the

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: Venipuncture to diagnosis doctor; Ability to respond to visual analog scale; Parental consent to participate in research; Children's oral consent to participate in research; Accompanied by a parent in the study and first venipuncture experience when admitted. Inclusion criteria: use of drugs that alter children's consciousness; Sensitivity to anesthetic spray and cold; Specific diseases (thyroid disorders, epilepsy, peripheral vascular disease or disease that causes loss of consciousness in children); Reject to participate; Severe pain; Urgent need for venipuncture; Get another non-pharmacological methods of pain control during the procedure and deficiency of physical and mental health to the extent that it is prevented from doing research (word - mentally - visual – physica).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: During and immediately after the intervention. Method of measurement: \ numeric scale & behavioral scale to measure pain.	—

Secondary

Measure	Time frame
Skin effects. Timepoint: During and after the intervention. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasood Rayani

Kerman University of Medical Sciences

mryani@kmu.ac.ir+98 34 1322 5077

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026